Extended-release naltrexone (XR-NTX) attenuates brain responses to alcohol cues in alcohol-dependent volunteers: A bold FMRI study

Oral naltrexone reduces heavy drinking, but is less consistent as an abstinence promoter, whereas once-monthly extended-release naltrexone (XR-NTX) also maintains abstinence. The present study sought to determine if alcohol cue reactivity is attenuated by XR-NTX. Twenty-eight detoxified alcohol-depe...

Full description

Saved in:
Bibliographic Details
Published inNeuroImage (Orlando, Fla.) Vol. 78; pp. 176 - 185
Main Authors Lukas, Scott E., Lowen, Steven B., Lindsey, Kimberly P., Conn, Nina, Tartarini, Wendy, Rodolico, John, Mallya, Gopi, Palmer, Christopher, Penetar, David M.
Format Journal Article
LanguageEnglish
Published Amsterdam Elsevier Inc 01.09.2013
Elsevier
Elsevier Limited
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Oral naltrexone reduces heavy drinking, but is less consistent as an abstinence promoter, whereas once-monthly extended-release naltrexone (XR-NTX) also maintains abstinence. The present study sought to determine if alcohol cue reactivity is attenuated by XR-NTX. Twenty-eight detoxified alcohol-dependent adult male and female volunteers received a single i.m. injection of either XR-NTX or placebo under double-blind conditions. An fMRI/cue reactivity procedure was conducted immediately before and two weeks after injection. At baseline, alcohol-related visual and olfactory cues elicited significant increases in orbital and cingulate gyri, inferior frontal and middle frontal gyri. Subsequently, brain activation was significantly altered in XR-NTX-treated individuals. These affected brain regions are associated with the integration of emotion, cognition, reward, punishment, and learning/memory, suggesting that XR-NTX attenuates the salience of alcohol-related cues. Such an effect on brain function may interrupt the processes associated with “slips” and relapse, which may account for XR-NTX's ability to maintain abstinence. •We exposed alcohol-dependent participants to alcohol and neutral cues during imaging•fMRI was measured before and 4 weeks after injection of extended release naltrexone•Naltrexone reduced the salience of olfactory and visual alcohol cues•Naltrexone altered the BOLD signal activation patterns•Naltrexone may interrupt the processes associated with “slips” and “relapse”
Bibliography:ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-News-1
ObjectType-Feature-3
content type line 23
ObjectType-Feature-1
ISSN:1053-8119
1095-9572
DOI:10.1016/j.neuroimage.2013.03.055